Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 7

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 7
---
 $427,985 
  
    Adjustments to Reconcile Net (Loss) Income to Net Cash Used in Operating Activities: 

    Depreciation 
     6,694  
     407 
  
    Amortization 
     10,103  
     8,207 
  
    Amortization of ROU Asset 
     -  
     13,517 
  
    Amortization of Capitalized Share-Based Payments 
     44,118  
     125,368 
  
    Share-Based Compensation under Equity Incentive Plan 
     142,645  
     - 
  
    Change in Fair Value of Derivative Liabilities 
     (5,105) 
     (1,740,847)
  
    Write-offs of Capitalized Patents 
     -  
     8,378 
  
    Changes in Operating Assets and Liabilities: 

    Accounts Receivable 
     (1,495) 
     (84,888)
  
    Prepaid and Other Assets 
     131,689  
     61,841 
  
    Inventory 
     (330,474) 
     30,792 
  
    Accounts Payable and Accrued Liabilities 
     261,905  
     23,243 
  
    Accrued Interest, net 
     19,855  
     (791)
  
    Reduction of Lease Liability 
     -  
     (13,650)
  
    Net Cash Used in Operating Activities 
     (1,597,366) 
     (1,140,438)

    CASH FLOWS FROM INVESTING ACTIVITIES 

    Capitalization of Patents 
     (2,804) 
     (726)
  
    Purchases of Fixed Assets 
     (2,678) 
     - 
  
    Acquisition of Intangibles 
     -  
     (9,088)
  
    Maturities of Short-Term Investments 
     1,708,000  
     - 
  
    Net Cash Provided by (Used in) Investing Activities 
     1,702,518  
     (9,814)

    CASH FLOWS FROM FINANCING ACTIVITIES 

    Net Proceeds from January 2024 Offering 
     -  
     1,898,296